The government on Tuesday said the deadly fungus caused by coronavirus causing vision loss in patients is a “mild disease” but “could seriously turn around”. The answer came when ENT surgeons at Sir Ganga Ram Hospital in Delhi encountered more than 12 cases of the Mucormycosis fungus within 15 days, causing loss of vision, removal of the nose and jaw, and 50 per cent mortality where there is brain involvement. .
“This is a destructive disease. We have to be careful. This could be a mild disease, but it can make a serious turn,” said Dr. VK Paul, a member (Health), NITI Aayog, today.
According to a report published by a news agency ANI, the ENT and Eye team at Sir Ganga Ram had to perform a resection in about 10 patients over the past fortnight, with about 50 per cent losing vision permanently. Five of these patients required critical care support, due to other associated complications. It said, citing Ganga Ram hospital, that there were five deaths in this subgroup.
Experts believe that patients with COVID-19 were more sensitive to this virus and said it was in the air. According to experts, it is a ubiquitous fungus and is present in the plant, animal and air, but attacks COVID-recovered patients because they have received steroids and have comorbidities.
“This is a virus and enters people with a weak immune system. This fungus enters the body and destroys the part where it comes from. The post-COVID patients receive a large dose of steroids to lessen the Cytokine storm, which it enables fungal infections such as lethal Mucormycosis to enter the body, ”said Dr Manish Munjal, a Senior ENT Surgeon at Sir Ganga Ram Hospital. ANI.
READ MORE: ‘Can’t deny chances of adverse events after vaccination begins’: Ministry of Health warns states, UTs
READ MORE: 29,000 cold chain points, 45 K of ice and 300 solar refrigerators to be used for vaccine driving.
Latest Indian News